Recruiting
Phase 3

Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation

Sponsor:

Stony Brook University

Code:

NCT05459974

Conditions

Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Colchicine 0.6 mg

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Stony Brook University on 2022-07-15.